Home

RICHARD KOPPES

CIK 1201944 · last filed 2013-04-19

RICHARD KOPPES is a corporate insider who has filed 25 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is −$244.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.1K

Companies

2

Total Filings

25

Lifetime Open-Market Net

-$244.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted Director 0 — — $24.0K 15 2010-09-30
AHG Director 9,067 $1.33 $12.1K -$268.6K 2 2008-06-06

Recent Filings

25 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-04-19 — Grant (A) — $0
2013-01-02 — Grant (A) — $0
2012-04-23 — Grant (A) — $0
2012-01-05 — Grant (A) — $0
2011-09-29 — Buy (P) +100,000 $15.4K
2011-09-29 — Grant (A) +100,000 $15.4K
2011-08-18 — Grant (A) +196,635 $33.4K
2010-09-30 VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted Disp (D) −54,523 $0 EDGAR
2010-07-06 VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted Grant (A) +153 $0 EDGAR
2010-05-13 VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted Grant (A) +2,677 $0 EDGAR
Showing 1–10 of 25
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.